▲Top Tier Newswire

News & sentiment

LLY (LLY) — News & AI sentiment

LLY news roundup. 6 stories in the last 24 hours, 60 in the past week, 186 over 30 days. Average 24-hour sentiment is 66/100 — bullish-leaning (50 is neutral). No insider transactions filed in the last 90 days. US House Periodic Transaction Reports (90-day window): 3 purchases (~$24K) and 3 sales (~$24K). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

6

avg sentiment 66/100

7d stories

60

avg sentiment 61.9/100

30d stories

186

avg sentiment 61.7/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

3 buys · 3 sells

Latest stories on LLY

Lilly says experimental obesity drug delivered weight loss across all stages of menopause

Seeking Alpha67 · bullishproduct/pr

6h ago

Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause

Morningstar67 · bullishproduct/pr

10h ago

Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause

PR Newswire67 · bullishproduct/pr

11h ago

Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause | LLY Stock News

StockTitan67 · bullishproduct/pr

11h ago

Eli Lilly’s (LLY) New Drug Gives Investors a Wake-Up Call as Data Bolsters the Stock’s Growth Story

TipRanks67 · bullishproduct/pr

13h ago

Notable healthcare headlines for the week: UnitedHealth, Medtronic, and Eli Lilly in focus

Seeking Alpha61 · neutralgeneral

13h ago

Eli Lilly reports broad benefits for experimental obesity drug retatrutide

Seeking Alpha77 · bullishproduct/pr

1d ago

Healthcare Stocks Can Benefit From AI, Too. But That Isn’t the Reason to Buy Them.

Yahoo Top58 · neutralproduct/pr

1d ago

Eli Lilly makes surprising retreat from major market

Yahoo Top33 · bearishgeneral

1d ago

Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are Missing

Yahoo Finance67 · bullishm&a

1d ago

Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications

Morningstar77 · bullishproduct/pr

1d ago

Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications | LLY Stock News

StockTitan77 · bullishproduct/pr

1d ago

Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications

PR Newswire77 · bullishproduct/pr

1d ago

Eli Lilly makes surprising retreat from major market

The Street33 · bearishgeneral

1d ago

Jim Cramer Says Eli Lilly CEO Is a “Terrific Steward of His Shareholders’ Capital”

Yahoo Top58 · neutralanalyst

1d ago

Prediction: Eli Lilly Will Reach $1,200 in 2026

Yahoo Top77 · bullishanalyst

1d ago

Novo's Wegovy Pill Isn't Just Beating Expectations -- It's Obliterating Them. Is the Beaten-Down Stock a Buy Now?

Yahoo Top67 · bullishearnings

2d ago

Eli Lilly Leads Medical Stocks To Watch, While Google Finds Support

Yahoo Finance58 · neutralgeneral

2d ago

Jim Cramer Sees Eli Lilly (LLY) Delivering ‘Knockout Punch’ to Competitors

TipRanks67 · bullishanalyst

2d ago

GLP-1 sales forecast increased to $150B at TD Cowen

Seeking Alpha67 · bullishanalyst

2d ago

Jim Cramer Details How Eli Lilly Could Defeat Competitors

Yahoo Top58 · neutralanalyst

2d ago

UnitedHealth, Eli Lilly lead healthcare rankings as sector gains momentum

Seeking Alpha67 · bullishgeneral

3d ago

CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors

Yahoo Top61 · neutralproduct/pr

3d ago

75% Upside For LLY Stock?

Yahoo Finance77 · bullishanalyst

3d ago

New PatentVest Pulse Report Maps the Emerging Muscle-Preservation Category Expanding the GLP-1 Opportunity | MDBH Stock News

StockTitan58 · neutralproduct/pr

3d ago

Open LLY in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →